Lord, Abbett & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-57,273
Closed -$7.11M 899
2018
Q2
$7.11M Buy
57,273
+3,717
+7% +$461K 0.02% 679
2018
Q1
$5.97M Sell
53,556
-142,534
-73% -$15.9M 0.02% 698
2017
Q4
$23.5M Sell
196,090
-17,791
-8% -$2.13M 0.07% 429
2017
Q3
$30M Buy
+213,881
New +$30M 0.09% 365
2016
Q1
Sell
-229,415
Closed -$43.8M 970
2015
Q4
$43.8M Buy
229,415
+160,287
+232% +$30.6M 0.13% 241
2015
Q3
$10.8M Sell
69,128
-23,051
-25% -$3.6M 0.03% 571
2015
Q2
$16.7M Sell
92,179
-40,150
-30% -$7.26M 0.04% 535
2015
Q1
$22.9M Sell
132,329
-15,830
-11% -$2.74M 0.06% 450
2014
Q4
$27.4M Buy
148,159
+87,210
+143% +$16.1M 0.07% 396
2014
Q3
$10.1M Sell
60,949
-3,443
-5% -$571K 0.03% 599
2014
Q2
$10.1M Buy
+64,392
New +$10.1M 0.02% 640
2014
Q1
Sell
-51,668
Closed -$6.88M 1097
2013
Q4
$6.88M Buy
+51,668
New +$6.88M 0.02% 755